Back
Salesforce, Inc. Vs. Viking Therapeutics, Inc. Industry Stock Comparison
Buy
59
CRM
Salesforce, Inc.
Last Price:
$262.23
Seasonality Move:
6.5%
Sell
48
VKTX
Viking Therapeutics, Inc.
Last Price:
$37.05
Seasonality Move:
35.18%
Buy
59
Salesforce, Inc. (CRM)
is a Buy
Is Salesforce, Inc. a Buy, Sell or Hold?
-
The current Salesforce, Inc. [CRM] share price is $262.23. The Score for CRM is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
CRM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Viking Therapeutics, Inc. (VKTX)
is a Sell
Is Viking Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Viking Therapeutics, Inc. [VKTX] share price is $37.08. The Score for VKTX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CRM Stock Price Chart
What is Salesforce, Inc.'s stock price today?
-
The Salesforce, Inc. share price today is $262.23Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRM is experiencing slight selling pressure.
VKTX Stock Price Chart
What is Viking Therapeutics, Inc.'s stock price today?
-
The Viking Therapeutics, Inc. share price today is $37.08The current trend is moderately bullish and VKTX is experiencing slight selling pressure.
CRM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.23 | Buy |
| Relative Strength Index (14 RSI): | 65.58 | Buy |
| Chaikin Money Flow: | -1577146 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (229.44 - 254.58) | Buy |
| Bollinger Bands (100): | (236.49 - 256.79) | Buy |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.6 | Buy |
| Relative Strength Index (14 RSI): | 52.83 | Buy |
| Chaikin Money Flow: | -1052344 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.16 - 38.9) | Buy |
| Bollinger Bands (100): | (27.45 - 37.75) | Buy |
CRM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 257.01 | Buy |
| 20-day SMA: | 241.89 | Buy |
| 50-day SMA: | 245.76 | Buy |
| 200-day SMA: | 258.37 | Buy |
| 8-day EMA: | 256.43 | Buy |
| 20-day EMA: | 248.56 | Buy |
| 50-day EMA: | 246.36 | Buy |
| 200-day EMA: | 258.9 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.45 | Sell |
| 20-day SMA: | 36.54 | Buy |
| 50-day SMA: | 35.68 | Buy |
| 200-day SMA: | 30 | Buy |
| 8-day EMA: | 37.02 | Buy |
| 20-day EMA: | 33.21 | Buy |
| 50-day EMA: | 22.2 | Buy |
| 200-day EMA: | 7.6 | Buy |
Salesforce, Inc. Earnings Growth & CRM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.47 per share, an increase next quarter of $0.20 per share, an increase this year of $1.83 per share, and an increase next year of $1.74 per share.
Viking Therapeutics, Inc. Earnings Growth & VKTX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.65 per share, and a decrease next year of $1.11 per share.
Salesforce, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||